Liver cancer, primarily hepatocellular carcinoma (HCC), exhibits highly heterogeneous
histological and molecular aberrations across tumors and within individual tumor nodules …

Objective Our study represents the first meta-analysis conducted to evaluate the prognostic
utility of the baseline prognostic nutritional index (PNI) in patients with gastrointestinal …

Objective To identify the risk factors associated with prognosis in patients with hepatocellular
carcinoma (HCC) treated with immune checkpoint inhibitors (ICI) via meta-analysis. And to …

The treatment of hepatocellular carcinoma (HCC), particularly advanced HCC, has been a
serious challenge. Immune checkpoint inhibitors (ICIs) are landmark drugs in the field of …

Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in
Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma …

Cancer is a leading cause of death globally. Immunotherapy has shown promise in treating
various types of cancer, but its effectiveness varies among patients. The Controlling …

Background: We conducted a meta-analysis to provide evidence-based results for the
predictive values of sarcopenia, skeletal muscle index, psoas muscle index and the …

The emergence of immune checkpoint inhibitors (ICIs) has provided a new treatment option
for patients with hepatocellular carcinoma (HCC). However, further evaluation is needed for …

In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative
approach in treating advanced hepatocellular carcinoma (HCC). Despite their success …

The effectiveness of tumor therapy, especially immunotherapy and oncolytic virotherapy,
critically depends on the activity of the host immune cells. However, various local and …